DK3033350T3 - Progesterone fosfatanaloger og anvendelser relateret dertil - Google Patents
Progesterone fosfatanaloger og anvendelser relateret dertil Download PDFInfo
- Publication number
- DK3033350T3 DK3033350T3 DK14835820.3T DK14835820T DK3033350T3 DK 3033350 T3 DK3033350 T3 DK 3033350T3 DK 14835820 T DK14835820 T DK 14835820T DK 3033350 T3 DK3033350 T3 DK 3033350T3
- Authority
- DK
- Denmark
- Prior art keywords
- progesterone
- uses related
- phosphate analogs
- analogs
- phosphate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0016—Oximes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361864681P | 2013-08-12 | 2013-08-12 | |
| PCT/US2014/050565 WO2015023593A1 (en) | 2013-08-12 | 2014-08-11 | Progesterone phosphate analogs and uses related thereto |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3033350T3 true DK3033350T3 (da) | 2021-08-30 |
Family
ID=52468610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14835820.3T DK3033350T3 (da) | 2013-08-12 | 2014-08-11 | Progesterone fosfatanaloger og anvendelser relateret dertil |
Country Status (5)
| Country | Link |
|---|---|
| US (5) | US9802978B2 (da) |
| EP (2) | EP3978507A1 (da) |
| DK (1) | DK3033350T3 (da) |
| ES (1) | ES2886839T3 (da) |
| WO (1) | WO2015023593A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009108804A2 (en) | 2008-02-26 | 2009-09-03 | Emory University | Steroid analogues for neuroprotection |
| US20130210785A1 (en) | 2012-02-15 | 2013-08-15 | Emory University | Progesterone analogs and uses related thereto |
| EP3978507A1 (en) | 2013-08-12 | 2022-04-06 | Emory University | Progesterone phosphate analogs and uses related thereto |
| US10752589B2 (en) * | 2016-03-14 | 2020-08-25 | Sphaera Pharma Pvt. Ltd. | Trigonelline based compounds |
| WO2018143162A1 (ja) * | 2017-01-31 | 2018-08-09 | 富山化学工業株式会社 | ヒドロキサム酸のプロドラッグである化合物またはその塩、凍結乾燥製剤、ＬｐｘＣ阻害剤および抗菌剤 |
| AU2022261742A1 (en) * | 2021-04-19 | 2023-11-02 | Neurotrauma Sciences Llc | Salts and crystalline forms of (3e) 3-[o-[(phosphonooxy)methyl]oxime]-pregn-4-ene-3, 20-dione and related uses |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2238476A1 (en) * | 1973-07-23 | 1975-02-21 | Aries Robert | Double esters of zeranol and natural hormones - and their implants for livestock, have protein anabolism props |
| US6331534B1 (en) * | 1994-08-04 | 2001-12-18 | Pherin Pharmaceuticals, Inc. | Steroids as neurochemical stimulators of the VNO to alleviate pain |
| US6245757B1 (en) | 1997-10-03 | 2001-06-12 | Research Corporation Technologies, Inc. | Use of progestins to treat ischemic event |
| US20020072509A1 (en) | 2000-10-11 | 2002-06-13 | Stein Donald Gerald | Methods for the treatment of a traumatic central nervous system injury |
| US7858603B2 (en) | 2003-03-11 | 2010-12-28 | Trophos | Use of derivatives of cholest-4-en-3-one as medicaments, pharmaceutical compositions containing same, novel derivatives and preparation method thereof |
| WO2005030704A1 (en) | 2003-09-24 | 2005-04-07 | Methylgene, Inc. | Inhibitors of histone deacetylase |
| DK1868614T3 (da) | 2005-03-24 | 2012-11-12 | Univ Emory | Dosisregime til behandling af en traumatisk hjerneskade med progesteron |
| GB2449293A (en) | 2007-05-17 | 2008-11-19 | Evotec | Compounds having Hsp90 inhibitory activity |
| GEP20125718B (en) | 2008-02-01 | 2012-12-25 | Takeda Pharmaceuticals Co | Oxim derivatives as hsp90 inhibitors |
| WO2009108804A2 (en) | 2008-02-26 | 2009-09-03 | Emory University | Steroid analogues for neuroprotection |
| US20100045596A1 (en) | 2008-08-21 | 2010-02-25 | Sony Ericsson Mobile Communications Ab | Discreet feature highlighting |
| WO2010088409A2 (en) | 2009-01-30 | 2010-08-05 | Emory University | Methods of neuroprotection using neuroprotective steroids and a vitamin d |
| US8435972B2 (en) | 2010-09-02 | 2013-05-07 | Emory University | Method for the treatment of central nervous system cancers and compositions related thereto |
| US20130210785A1 (en) | 2012-02-15 | 2013-08-15 | Emory University | Progesterone analogs and uses related thereto |
| EP3978507A1 (en) | 2013-08-12 | 2022-04-06 | Emory University | Progesterone phosphate analogs and uses related thereto |
-
2014
- 2014-08-11 EP EP21186868.2A patent/EP3978507A1/en active Pending
- 2014-08-11 WO PCT/US2014/050565 patent/WO2015023593A1/en active Application Filing
- 2014-08-11 US US14/911,807 patent/US9802978B2/en active Active
- 2014-08-11 EP EP14835820.3A patent/EP3033350B1/en active Active
- 2014-08-11 DK DK14835820.3T patent/DK3033350T3/da active
- 2014-08-11 ES ES14835820T patent/ES2886839T3/es active Active
-
2017
- 2017-10-09 US US15/728,459 patent/US10487109B2/en active Active
-
2019
- 2019-10-11 US US16/599,892 patent/US11053276B2/en active Active
-
2021
- 2021-06-28 US US17/360,614 patent/US11725025B2/en active Active
-
2023
- 2023-06-20 US US18/211,816 patent/US20230357309A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3033350B1 (en) | 2021-07-28 |
| EP3978507A1 (en) | 2022-04-06 |
| US20160194351A1 (en) | 2016-07-07 |
| WO2015023593A1 (en) | 2015-02-19 |
| EP3033350A1 (en) | 2016-06-22 |
| US20200255470A1 (en) | 2020-08-13 |
| US20230357309A1 (en) | 2023-11-09 |
| US20180094018A1 (en) | 2018-04-05 |
| US11053276B2 (en) | 2021-07-06 |
| EP3033350A4 (en) | 2017-03-15 |
| US9802978B2 (en) | 2017-10-31 |
| US11725025B2 (en) | 2023-08-15 |
| US20210395294A1 (en) | 2021-12-23 |
| ES2886839T3 (es) | 2021-12-21 |
| US10487109B2 (en) | 2019-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2968443T3 (da) | Hepcidinanaloger og anvendelser deraf | |
| DK3043784T3 (da) | Arylethere og anvendelser deraf | |
| ES2969384T3 (es) | Vaporizador | |
| FI20135956A (fi) | Kiinnitin | |
| DK3008168T3 (da) | Sc-celler og sammensætninger og fremgangsmåde til dannelse deraf | |
| ES2969363T3 (es) | Formulaciones | |
| BR302013004540S1 (pt) | Configuração aplicada em jóias | |
| BR302013004506S1 (pt) | Configuração aplicada em jóias | |
| BR302013004355S1 (pt) | Configuração aplicada em jóias | |
| DK3003039T3 (da) | Methyl/fluor-pyridinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser og fluor-pyrimidinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser | |
| DK3063144T3 (da) | Antiparasitære og pesticid-isoxazolinforbindelser | |
| DK2986722T3 (da) | Manipulerede phenylalaninammoniak-lyasepolypeptider | |
| DK2962100T3 (da) | Tuberkulosebiomarkører og anvendelser deraf | |
| DK3077467T3 (da) | Sikkativsammensætning og anvendelse deraf | |
| DK3030549T3 (da) | Pyridazinonforbindelser og anvendelser deraf | |
| DK2991565T3 (da) | Ekspanderbar ballon | |
| DK3029038T3 (da) | Tetrazolinonforbindelse og anvendelse deraf | |
| DK2964767T3 (da) | Toksingener og fremgangsmåder til anvendelse deraf | |
| DK2992104T3 (da) | Fremgangsmåde til ekspression | |
| DK2767269T3 (da) | Terapeutisk anordning | |
| FR3014969B1 (fr) | Fixation temporaire | |
| DK3068505T3 (da) | Spillesystem og -fremgangsmåde | |
| DK3033350T3 (da) | Progesterone fosfatanaloger og anvendelser relateret dertil | |
| DK3035886T3 (da) | Inhalator | |
| DK2956010T4 (da) | Fedtsammensætning |